Consumer Injury Lawyers Investigating Voluntary Darvon/Darvocet Recall From U.S. Market
Last week, Xanodyne, the manufacturer of propoxyphene, which is also known as Darvon/Darvocet, agreed to recall of all their Darvon/ Darvocet drugs after increased pressure from the FDA.
Xanodyne has had a history of scrutiny since 1957 when Darvon was introduced as a painkiller to relieve mild to moderate post-surgical pain.
To date 3,000 serious reports of Darvon and Darvocet problems have been identified, most involving heart problems, suicides, addiction and overdoses. In addition, the FDA indicated that Darvocet and Darvon provide little to no more pain relief than taking acetaminophen alone.
The FDA showed concern for the safety of Darvon/Darvocet users beginning in January 2009, when an advisory committee meeting addressed the health concerns and public safety surrounding propoxyphene. The committee voted 14 to 12 against the continued marketing of propoxyphene products. In the summer of 2009, the European Medicines Agency (EMEA) asked the manufacturer to end all marketing and advertising in the European Union. And in the United States, the FDA required that a new warning be added to the drug label which informed patients and health care professionals to the risk of a fatal overdose.
If you or a loved one experienced a serious side effect associated with taking Darvon or Darvocet, you may be entitled to compensation for your medical bills, pain and suffering, lost wages, and other injuries. For more information about filing a Darvon or Darvocet lawsuit, contact an attorney at Bernstein Liebhard LLP at (877) 779-1414 or at email@example.com.
Since 1993, Bernstein Liebhard has pursued hundreds of cases on behalf of injured consumers and shareholders, recovering almost $3 billion for our clients. For eight consecutive years, The National Law Journal has named the Firm as one of the top plaintiff’s litigation firms in the country.
ATTORNEY ADVERTISING. © 2010 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (212) 779-1414. Prior results do not guarantee or predict a similar outcome with respect to any future matter.
Contact Information Felecia L. Stern, Esq. Seth Ottensoser, Esq. firstname.lastname@example.org (877) 779-1414